The growing prevalence of chronic diseases, rising demand for enteral feeding devices in-home care settings, increasing adoption of enteral nutrition, rising geriatric population, an increasing number of preterm births, shift from parenteral to enteral nutrition, and growing awareness regarding enteral nutrition are some of the key factors driving the global enteral feeding devices market.
BRUSSELS, BELGIUM, August 01, 2022: Nutrition plays an important role in maintaining health as well as in the prevention and management of a variety of diseases. Enteral feeding is the delivery of nutrients directly into the digestive tract through a feeding tube.
Enteral feeding devices are devices that are placed in patients who have a functional and accessible gastrointestinal (GI) tract but are not able to consume or absorb enough nutrients to sustain adequate nutrition and hydration. For many individuals, enteral nutrition support is a lifesaving modality to prevent or treat a depleted nutrient state that can lead to tissue breakdown, compromised immune function, and poor wound healing. The main types of enteral feedings devices available in the market are nasogastric tube (NGT), orogastric tube (OGT), gastrostomy tube, jejunostomy tube, nasoenteric tube, and oroenteric tube.
Shift towards Enteral Nutrition from Parenteral Nutrition Drives the Enteral Feeding Devices Market
In general, medical providers typically recommend enteral feeding over parenteral feeding. This is due to enteral nutrition being less costly, easier on the body, and presents fewer complications. For people recovering from an illness or injury, it presents a safe and effective way to maintain energy and promote healing. Moreover, feeding tubes are easier to clean and sterilize than IVs, catheters, or ports.
Growing Adoption of Home Enteral Nutrition (HEN) Fuels the Demand
HEN can be recommended for a diversity of people with many different conditions and circumstances. Enteral nutrition is started during a hospital stay and continued as a long-term home enteral nutrition therapy. Because of the increasing expenses in the hospital, HEN is considered quite an essential cost-effective and safe treatment for patients who require continuous nutritional support after being discharged. Thus, increased adoption of HEN in-home care is expected to fuel the demand for the enteral feeding devices market in the coming period.
Explore Detailed Insights on Enteral Feeding Devices Market @ https://meditechinsights.com/enteral-feeding-devices-market/
Key Market Challenges: Enteral Feeding Devices Market
Reimbursement issues and complications associated with enteral feeding tubes are some of the key factors that are likely to hamper the growth of the enteral feeding devices market. Some of the complications associated with enteral feeding devices are skin irritation, aspiration, refeeding syndrome, nausea, vomiting, diarrhoea, tube blockage, and tube dislodging.
North America Expected to Continue Holding Major Share in the Enteral Feeding Devices Market
North America currently holds a major share in the global enteral feeding devices market. It is expected to continue to hold a major share in the coming years due to the growing prevalence of chronic diseases, rising aging population, adoption of technologically advanced products, and growing awareness regarding enteral nutrition in the region.
Competitive Landscape Analysis: Enteral Feeding Devices Market
Some of the key players operating in the enteral feeding devices market are Danone, B. Braun Melsungen AG, Cook Medical, Conmed Corporation, BD, Abbott Laboratories, Vygon SA, among others.
Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market
Players operating in this market are adopting organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner market share. For instance,
Get Customized Report on Enteral Feeding Devices Market @ https://meditechinsights.com/enteral-feeding-devices-market/
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
© 1985 - 2022 BioSpace.com. All rights reserved. Powered by Madgex Job Board Software